A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study.
James I GellerNicholas G CostYueh-Yun ChiBrett TornwallMariana CajaibaElizabeth J PerlmanYeonil KimElizabeth A MullenRichard D GlickGeetika KhannaNajat C DawPeter F EhrlichConrad V FernandezJeffrey S Domenull nullPublished in: Cancer (2020)
Favorable short-term outcomes can be achieved without adjuvant therapy in children and adolescents with completely resected RCC, independent of lymph node status. A prospective study of patients with tRCC and RMC with M1 or recurrent disease is needed to optimize treatment.